The anti-tumor activity of CDK2 inhibition alone or in combination with other anti-cancer agents in human cancers

被引：0
|
作者：
Chen, Yaoyu
Chen, Jinhong
Guo, Yali
Pang, Wei
Zhou, Tingru
Liu, Xipan
Schomer, Nathan
Li, Fang
Liang, Jiaqi
Sheng, Qing
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B173
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 1-2 study of TI-061 alone and in combination with other anti-cancer agents in patients with advanced malignancies.
    Evans, T. R. Jeffry
    Italian, Antoine
    Eskens, Ferry
    Symeonides, Stefan Nicholas
    Bexon, Alice Susannah
    Graham, Philippa
    Hinds, David
    Manning, Pamela
    Chanda, Sanjay
    Karr, Robert
    Bhargava, Pankaj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] THYMIDINE AS AN ANTI-CANCER AGENT, ALONE OR IN COMBINATION - A BIOCHEMICAL APPRAISAL
    ELLIMS, PH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 10 (01) : 1 - 6
  • [43] Discovery of SCR-8079, a novel and selective CDK2/4/6 inhibitor overcomes the resistance to CDK4/6 inhibition and demonstrates broad anti-tumor activities in breast cancers
    Zhou, Feng
    Yang, Guimei
    Tang, Feng
    Zhang, Yan
    Yang, Wenqing
    Xue, Liting
    Chen, Ping
    Tang, Renhong
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer
    Wang, Shunyou
    Lan, Lucy
    Janes, Mathew
    Jessen, Katti
    Kessler, Linda
    Kucharski, Jeff
    Guo, Xin Xin
    Staunton, Jocelyn
    Elia, Marikka
    Banerjee, Urmi
    Stewart, Josh
    Dartania, Levan
    Li, Liansheng
    Chan, Katrina
    Martin, Mike
    Ren, Pingda
    Rommei, Christian
    Liu, Yi
    CANCER RESEARCH, 2012, 72
  • [45] Inhibition of A2AR induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical and clinical studies
    Willingham, Stephen
    Hotson, Andrew
    Ho, Po
    Choy, Carmen
    Walter, Kim
    Yusko, Erik
    Benzeno, Sharon
    Laport, Ginna
    Miller, Richard
    McCaffery, Ian
    CANCER RESEARCH, 2017, 77
  • [46] Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti-Cancer Immunotherapy
    Xiang, D.
    Sharma, V. R.
    Freter, C. E.
    Yan, J.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (25) : 4298 - 4305
  • [47] ANTI-TUMOR AGENTS .32. SYNTHESIS AND ANTI-TUMOR ACTIVITY OF CYCLOPENTENONE DERIVATIVES RELATED TO HELENALIN
    LEE, KH
    MAR, EC
    OKAMOTO, M
    HALL, IH
    JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (08) : 819 - 822
  • [48] Mechanistic evaluation of the anti-tumor activities of 2-fluorofucose alone and in combination with anti-idiotype vaccination
    Okeley, Nicole M.
    Zeng, Weiping
    Levengood, Matthew R.
    McEarchern, Julie A.
    Jonas, Mechthild
    Duniho, Steven
    Senter, Peter D.
    Law, Che L.
    CANCER RESEARCH, 2014, 74 (19)
  • [49] SENSITIVITY OF ANTI-CANCER AGENTS ON HUMAN GASTRIC CANCERS TRANSPLANTED INTO NUDE-MICE
    TANI, T
    NISHIMAWARI, K
    NOSOH, Y
    HATTORI, T
    JAPANESE JOURNAL OF SURGERY, 1981, 11 (05): : 353 - 358
  • [50] Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
    Chow, Ariel
    Pang, Roberta
    Chu, Andrew
    Ng, Lui
    Poon, Ronnie
    CANCER RESEARCH, 2011, 71
12345